← Back to the feed

Polaroid Therapeutics AG

History from 23 Mar 2023

UID

CHE-358.582.058

Legal form

AG

Canton

ZH

Founded

23 Mar 2023

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 28 Mar 2023 · legal date 23 Mar 2023

   Company formed

   Founded 23 Mar 2023

   SHAB HR01-1005710368 ↗

2. SHAB published 9 May 2023 · legal date 28 Apr 2023

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   100’065.90 → 175’818.60

   Shares

   1’000’659 → 1’758’186

   New shares, % of post-step shares

   43.1% (757’527 new)

   Aktienkapital neu: CHF 175'818.60 [bisher: CHF 100'065.90]. Liberierung Aktienkapital neu: CHF 175'818.60 [bisher: CHF 100'065.90]. Aktien neu: 1'758'186 Namenaktien zu CHF 0.10 [bisher: 1'000'659 Namenaktien zu CHF 0.10].

   SHAB HR02-1005741376 ↗

3. SHAB published 10 Jul 2024 · legal date 3 Jul 2024

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   175’818.60 → 248’818.60

   Shares

   1’758’186 → 2’488’186

   New shares, % of post-step shares

   29.3% (730’000 new)

   Aktienkapital neu: CHF 248'818.60 [bisher: CHF 175'818.60]. Liberierung Aktienkapital neu: CHF 248'818.60 [bisher: CHF 175'818.60]. Aktien neu: 2'488'186 Namenaktien zu CHF 0.10 [bisher: 1'758'186 Namenaktien zu CHF 0.10].

   SHAB HR02-1006080325 ↗

4. SHAB published 21 Jan 2025 · legal date 20 Dec 2024

   Capital increase

   Not assessed

   Issued from conditional capital

   Nominal capital

   248’818.60 → 253’373.90

   Shares

   2’488’186 → 2’533’739

   New shares, % of post-step shares

   1.8% (45’553 new)

   Aktienkapital neu: CHF 253'373.90 [bisher: CHF 248'818.60]. Liberierung Aktienkapital neu: CHF 253'373.90 [bisher: CHF 248'818.60]. Aktien neu: 2'533'739 Namenaktien zu CHF 0.10 [bisher: 2'488'186 Namenaktien zu CHF 0.10].

   SHAB HR02-1006233462 ↗

5. SHAB published 23 Jul 2025 · legal date 10 Jul 2025

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   253’373.90 → 313’373.90

   Shares

   2’533’739 → 3’133’739

   New shares, % of post-step shares

   19.1% (600’000 new)

   Aktienkapital neu: CHF 313'373.90 [bisher: CHF 253'373.90]. Liberierung Aktienkapital neu: CHF 313'373.90 [bisher: CHF 253'373.90]. Aktien neu: 3'133'739 Namenaktien zu CHF 0.10 [bisher: 2'533'739 Namenaktien zu CHF 0.10]. Die Gesellschaft hat mit Beschluss vom 10.07.2025 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.

   SHAB HR02-1006391802 ↗

6. SHAB published 23 Jul 2025 · legal date 10 Jul 2025

   Capital band adopted

   SHAB HR02-1006391802 ↗

7. SHAB published 16 Mar 2026 · legal date 10 Mar 2026

   Capital increase

   ○○○Capital increased

   Issued from conditional capital

   Nominal capital

   313’373.90 → 314’546.40

   Shares

   3’133’739 → 3’145’464

   New shares, % of post-step shares

   0.4% (11’725 new)

   Aktienkapital neu: CHF 314'546.40 [bisher: CHF 313'373.90]. Liberierung Aktienkapital neu: CHF 314'546.40 [bisher: CHF 313'373.90]. Aktien neu: 3'145'464 Namenaktien zu CHF 0.10 [bisher: 3'133'739 Namenaktien zu CHF 0.10].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5
   • A small increment typical of employee share options.−1.0
   • Shares issued out of conditional capital, as when options are exercised.−1.0

   Classifier score 0.04 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006596528 ↗

8. SHAB published 30 Jun 2026 · legal date 19 Jun 2026

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   314’546.40 → 364’621.90

   Shares

   3’145’464 → 3’646’219

   New shares, % of post-step shares

   13.7% (500’755 new)

   Aktienkapital neu: CHF 364'621.90 [bisher: CHF 314'546.40]. Liberierung Aktienkapital neu: CHF 364'621.90 [bisher: CHF 314'546.40]. Aktien neu: 3'646'219 Namenaktien zu CHF 0.10 [bisher: 3'145'464 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006691945 ↗

Published by 8 Oct 2026